Scripps Research Institute: Seeing Double - Designing Drugs That Target "twin" Cancer Proteins
October 01, 2024
October 01, 2024
LA JOLLA, California, Oct. 1 (TNSres) -- The Scripps Research Institute issued the following news:
* * *
Scripps Research scientists used knowledge about a protein to characterize drugs that selectively bind to its "twin," or paralog.
* * *
Some proteins in the human body are easy to block with a drug; they have an obvious spot in their structure where a drug can fit, like a key in a lock. But other proteins are more difficult to targ . . .
* * *
Scripps Research scientists used knowledge about a protein to characterize drugs that selectively bind to its "twin," or paralog.
* * *
Some proteins in the human body are easy to block with a drug; they have an obvious spot in their structure where a drug can fit, like a key in a lock. But other proteins are more difficult to targ . . .